ABC Guide to Travel Health - Vaccines, Vaccinations

ABC Guide Index

Previous topic Next topic
Hepatitis C

Hepatitis C is a serious viral infection of the liver caused by the hepatitis C virus (HCV).26 Most HCV infections are asymptomatic. In cases of HCV that are symptomatic, the symptoms may include stomach pains, nausea, vomiting, fatigue and sometimes jaundice (a yellowing of the skin and whites of the eyes).26,27 Seventy-five to 85% of people infected with HCV develop a long-lasting chronic infection, which may lead to scarring of the liver with impaired function and/or liver cancer.26,27

Transmission26,27
Transmission is from person-to-person, primarily through activities that result in the exchange of blood. For example the infection can be spread through transfusion of contaminated blood and blood products and the use of contaminated needles, syringes and other instruments used for injections and other skin-piercing procedures. Sexual transmission of hepatitis C occurs rarely.

Geographical distribution26,27
Worldwide, however the prevalence is higher (up to 15%) in some countries in Africa and Asia, and highest (>15%) in Egypt.

See hepititis C distribution map

Risk for travellers26,27
Travellers are at risk if they practise unsafe behaviour involving the use of contaminated needles or syringes for injection, acupuncture, piercing or tattooing. An accident or medical emergency requiring blood transfusion may result in infection if the blood has not been screened for HCV.

Precautions and prevention26,27

  • There is no vaccine to prevent hepatitis C infection.
  • Adopt safe sexual practices.
  • Do not share other persons’ razors.
  • Avoid the use of any potentially contaminated instruments for injection or other skin-piercing activities , such as acupuncture, piercing or tattooing.

(Please read the Disclaimer before using the ABC Guide to Travel Health).

 

Back to ABC Guide Index

Back to top

Well to go
This site is owned and operated by GlaxoSmithKline Australia Pty Ltd to support The Travel Health Advisory Group (THAG).
The content has been reviewed and endorsed by Dr Bernie Hudson Chairperson of THAG on behalf of THAG.
GlaxoSmithKline Australia Pty. Ltd. ABN 47 100 162 481. 1061 Mountain Highway, Boronia, Victoria 3155
© GlaxoSmithKline Australia Pty Ltd. 2006